Article
Phage display and pharmacogenomics.
Pharmacogenomics - 1 May 2000
Ladner R C
Abstract excerpt
Surface display of genetic diversity is a technology that can produce specific binding agents for almost any target molecule, and is especially well suited for making agents that bind specific proteins. Until now, pharmacogenomic studies have followed the response of cells to drugs and other agents by tracking the mRNAs that encode the proteins of interest, because it is relatively easy to produce nucleic acid...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
